Avidity to seek accelerated approval for FSHD drug; Axsome to run another trial
Plus, news about Mosanna Therapeutics, Concentra Biosciences, Elevation Oncology, Keros, TuHURA Biosciences and PolyPid: Avidity Biosciences says FDA is open to accelerated approval for FSHD drug: The RNA drug company
Plus, news about Mosanna Therapeutics, Concentra Biosciences, Elevation Oncology, Keros, TuHURA Biosciences and PolyPid:
Avidity Biosciences says FDA is open to accelerated approval for FSHD drug: The RNA drug company
